About us

MISSION
Our mission is to leverage our outstanding technologies and know-how to support researchers and manufacturers in realizing higher success rates, greater yields and reduced cost of goods when producing proteins.
VISION
Our vision is to be the obvious choice for technologies and services for microbial applications within the life science industries.
Vectron Biosolutions was founded in 2008 as a result of more than 15 years of research in Professor Svein Valla's research group at the Department of Biotechnology at the University of Science and Technology (NTNU) in Trondheim, Norway.
Professor Svein Valla was a world-leading expert on gene expression in bacteria and vector technology with more than 100 publications in peer-reviewed scientific journals. His research has resulted in a novel technology platform for production of recombinant proteins that can be used for higher protein production levels at lower costs and increased solubility. This innovative technology comprises Vectron's core technology.

To complement this expression vector technology, Vectron Biosolution acquired its microbial secretion technology in 2021. The secretion technology was developed by Professor Kelly Hughes at the University of Utah. Hughes is a world-leading scientist on microbial flagella with more than 100 publications on the topic.
61%
Pharma
16%
CMO
16%
Industrial enzymes
6%
Academic
unique solutions for unique problems

key partner to
the entire life
science industry

Vectron's services and technologies are available to any company or research group that are looking for optimal microbial production strains for their proteins.

This could be a pharmaceutical company having issues with inclusion body formation while in pre-clinical development of their drug or an enzyme company looking for even higher titers of their new product. To us, any protein is a problem looking for a solution.
why us

VECTRON BIOSOLUTIONS

01
Record-high titers
Get the highest titers of biologically active, soluble protein with our proprietary expression technologies
02
Microbial secretion
Reduce downstream costs and turnover times with our innovative microbial secretion technology
03
Soluble production
Avoid issues with inclusion body formation, degradation and aggregation from our tailor-made solutions
Meet our team

Board and Management

We are scientists. Vectron is made-up of a small team of scientists working on developing outstanding production strains for our customers, developing new expression technologies, and improving our existing technologies.

The majority of our employees hold a PhD and our combined experience with gene expression and protein production is more than 50 years. This makes us uniquely positioned to troubleshoot issues with sub-optimal protein production, and to deliver the bespoke scientific solutions that are needed.

Management
TROND ERIK VEE AUNE. 
CEO at Vectron Biosolutions- Microbial protein production experts
Trond Erik Vee Aune
CEO
JOSTEIN MALMO.
CSO at Vectron Biosolutions- Expert in tailor-made Expression Vectors
Jostein Malmo
CSO
Board of Directors
REINHARD VOGT Board member at Vectron Biosolution (Partner of Dynamik Capital)
Reinhard Vogt
Board member
Partner of Dynamik Capital
JAN ERIK FOSS Board member at Vectron Biosolution (CEO at Leiv Eiriksson)
Jan Erik Foss
Board member
CEO at Leiv Eiriksson
CARL-ÅKE CARLSSON
Chairman at Vectron Biosolutions
(CEO at Xellia Pharmaceuticals)
Carl-AAke Carlsson
Chairman
CEO at Xellia Pharmaceuticals
TOM PIKE Board member Life science industry professional at Vectron Biosolutions
Tom Pike
Board member
Life science industry professional
TROND ERIK VEE AUNE. 
CEO at Vectron Biosolutions- Microbial protein production experts
Trond Erik Vee Aune
CEO
GET IN TOUCH
Do you want to know more about our innovative, proprietary technologies or how our services can help you?
CONTACT US